Related references
Note: Only part of the references are listed.Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
Rebecca Landy et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program
C. Sarai Racey et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Cost-effectiveness studies of HPV self-sampling: A systematic review
Colin Malone et al.
PREVENTIVE MEDICINE (2020)
Geographic and sociodemographic differences in cervical cancer screening modalities
Ann Goding Sauer et al.
PREVENTIVE MEDICINE (2020)
Diagnosis and Management of Adenocarcinoma in Situ A Society of Gynecologic Oncology Evidence-Based Review and Recommendations
Deanna Teoh et al.
OBSTETRICS AND GYNECOLOGY (2020)
A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
Maria Demarco et al.
ECLINICALMEDICINE (2020)
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
Rebecca B. Perkins et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)
Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity Trial
Thomas C. Wright et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015
Julia Warner Gargano et al.
CLINICAL INFECTIOUS DISEASES (2019)
Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014
Nancy M. McClung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trial
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2019)
Bethesda 2014 Implementation and Human Papillomavirus Primary Screening Practices of Laboratories Participating in the College of American Pathologists PAP Education Program
Diane Davis Davey et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England
Irenjeet Bains et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Tim Palmer et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016
Nancy M. McClung et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States
Farhad Islami et al.
PREVENTIVE MEDICINE (2019)
Rural-Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010-2014
Lulu Yu et al.
PREVENTING CHRONIC DISEASE (2019)
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2019)
Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey
Nancy M. McClung et al.
JOURNAL OF ADOLESCENT HEALTH (2019)
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018
Tanja Y. Walker et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
Alejandra Castanon et al.
JOURNAL OF MEDICAL SCREENING (2019)
Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results
Philip E. Castle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening
Kathy L. MacLaughlin et al.
JOURNAL OF WOMENS HEALTH (2019)
Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results
Philip E. Castle et al.
PREVENTIVE MEDICINE (2019)
Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis
Ping Teresa Yeh et al.
BMJ GLOBAL HEALTH (2019)
Should Self-Sampling Be an Option for Women in the United States?
Jose Jeronimo et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2019)
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection
Anna-Barbara Moscicki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2019)
Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study
Geric Maura et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2018)
HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer
Gui Liu et al.
AIDS (2018)
Cervical Cancer Screening Intervals Preferred by US Women
Crystale Purvis Cooper et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2018)
The natural history of human papillomavirus infection
Silvia de Sanjose et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2018)
Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society
Andrew M. D. Wolf et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a US healthcare system
Rachel L. Winer et al.
CONTEMPORARY CLINICAL TRIALS (2018)
Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines
Kine Pedersen et al.
EUROPEAN JOURNAL OF CANCER (2018)
The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
Mark H. Stoler et al.
GYNECOLOGIC ONCOLOGY (2018)
Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial (vol 320, pg 43, 2018)
G. S. Ogilvie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
HPV prevalence and HPV-related dysplasia in elderly women
Ruth S. Hermansson et al.
PLOS ONE (2018)
How confident can we be in the current guidelines for exiting cervical screening?
Patti E. Gravitt et al.
PREVENTIVE MEDICINE (2018)
Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting
Katharine A. Rendle et al.
PREVENTIVE MEDICINE (2018)
Patterns and Trends in Cancer Screening in the United States
Ingrid J. Hall et al.
PREVENTING CHRONIC DISEASE (2018)
Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis
Christine Bekos et al.
SCIENTIFIC REPORTS (2018)
Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia
Karen Canfell et al.
BMJ OPEN (2018)
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
Karoliina Tainio et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis
Karoliina Tainio et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Joy Melnikow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Screening for Cervical Cancer in Primary Care A Decision Analysis for the US Preventive Services Task Force
Jane J. Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2017
Tanja Y. Walker et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study
Talia Malagon et al.
LANCET ONCOLOGY (2018)
Trends in Cervical Cancer Screening in California's Family Planning Program
Heike Thiel de Bocanegra et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2018)
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer An Observational Cohort Study
Philip E. Castle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Racial/Ethnic Disparities in Cervical Cancer Screening Services Among Contractors of the Connecticut Breast and Cervical Cancer Early Detection Program
Morgan A. Pratte et al.
HEALTH EQUITY (2018)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Jane J. Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Why does cervical cancer occur in a state-of-the-art screening program?
Philip E. Castle et al.
GYNECOLOGIC ONCOLOGY (2017)
Harms of cervical cancer screening in the United States and the Netherlands
Dik Habbema et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014
Sara E. Oliver et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States
Wonsuk Yoo et al.
PLOS ONE (2017)
Primary HPV testing recommendations of US providers, 2015
Crystale Purvis Cooper et al.
PREVENTIVE MEDICINE (2017)
Understanding women's hesitancy to undergo less frequent cervical cancer screening
Mary A. Gerend et al.
PREVENTIVE MEDICINE (2017)
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm
Joseph E. Tota et al.
PREVENTIVE MEDICINE (2017)
National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey
Meg Watson et al.
PREVENTIVE MEDICINE (2017)
Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
Jiangrong Wang et al.
PLOS MEDICINE (2017)
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
Karen Canfell et al.
PLOS MEDICINE (2017)
Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013
Judith van der Horst et al.
CANCER MEDICINE (2017)
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016
Tanja Y. Walker et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era
Vicki B. Benard et al.
JAMA ONCOLOGY (2017)
Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer
Emily A. Burger et al.
CLINICAL INFECTIOUS DISEASES (2017)
Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening
Mary C. White et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2017)
Hysterectomy-Corrected Cervical Cancer Mortality Rates Reveal a Larger Racial Disparity in the United States
Anna L. Beavis et al.
CANCER (2017)
Human Papillomavirus Genotyping Testing Practice in 2014 Results of a College of American Pathologists National Survey
Chengquan Zhao et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Case-control study of cervical cancer and gynecologic screening: A SEER-Medicare analysis
Karin A. Rosenblatt et al.
GYNECOLOGIC ONCOLOGY (2016)
Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
Alejandra Castanon et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
Kate T. Simms et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Regression and Progression Predictors of CIN2 in Women Younger Than 25 Years
Diede L. Loopik et al.
Journal of Lower Genital Tract Disease (2016)
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis
Steffie K. Naber et al.
PLOS ONE (2016)
Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
Pablo Alonso-Coello et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
Pablo Alonso-Coello et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians
George F. Sawaya et al.
ANNALS OF INTERNAL MEDICINE (2015)
An Assessment of Gynecological Cytology Screening Practices Among Health Care Providers Nationwide
May Darwish-Yassine et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Human Papillomavirus Testing and Reporting Rates in 2012 Results of a College of American Pathologists National Survey
Chengquan Zhao et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
Warner K. Huh et al.
GYNECOLOGIC ONCOLOGY (2015)
Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2015)
Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society
Kevin C. Oeffinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Education efforts may contribute to wider acceptance of human papillomavirus self-sampling
Victoria Crofts et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2015)
Cervical Screening and Cervical Cancer Death Among Older Women: A Population-Based, Case-Control Study
Alison S. Rustagi et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Screening Pelvic Examinations in Asymptomatic, Average-Risk Adult Women: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians
Hanna E. Bloomfield et al.
ANNALS OF INTERNAL MEDICINE (2014)
Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
R. Landy et al.
BRITISH JOURNAL OF CANCER (2014)
Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America
Henry Masur et al.
CLINICAL INFECTIOUS DISEASES (2014)
No Evidence for Synergy Between Human Papillomavirus Genotypes for the Risk of High-Grade Squamous Intraepithelial Lesions in a Large Population-Based Study
Nicolas Wentzensen et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Role of cervical screening in older women
Laurie Elit
MATURITAS (2014)
Cervical Screening at Age 50-64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
Alejandra Castanon et al.
PLOS MEDICINE (2014)
Follow-up Outcomes of a Large Cohort of Low-Risk Women With Negative Imaged Liquid-Based Cytology and Negative HPV Test Results
Chengquan Zhao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Counterpoint: Cervical Cancer Screening Guidelines-Approaching the Golden Age
Sandra D. Isidean et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Challenges in Cervical Cancer Prevention A Survey of U.S. Obstetrician-Gynecologists
Rebecca B. Perkins et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2013)
A cross sectional study of HPV type prevalence according to age and cytology
Elena Argyri et al.
BMC INFECTIOUS DISEASES (2013)
Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years
A. Castanon et al.
BRITISH JOURNAL OF CANCER (2013)
Efficacy of screening in preventing cervical cancer among older women
Aruna Kamineni et al.
CANCER CAUSES & CONTROL (2013)
Five-Year Risk of CIN 3+to Guide the Management of Women Aged 21 to 24 Years
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
Association of Insurance Status and Age With Cervical Cancer Stage at Diagnosis: National Cancer Database, 2000-2007
Stacey A. Fedewa et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2012)
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Age-Specific Effectiveness of the Finnish Cervical Cancer Screening Programme
Stefan Lonnberg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Contributions of Recent and Past Sexual Partnerships on Incident Human Papillomavirus Detection: Acquisition and Reactivation in Older Women
Anne F. Rositch et al.
CANCER RESEARCH (2012)
Screening history preceding a diagnosis of cervical cancer in women age 65 and older
Helen Dinkelspiel et al.
GYNECOLOGIC ONCOLOGY (2012)
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
John T. Schiller et al.
VACCINE (2012)
Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland
Maarit K. Leinonen et al.
BRITISH MEDICAL JOURNAL (2012)
Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the US Preventive Services Task Force
Kimberly K. Vesco et al.
ANNALS OF INTERNAL MEDICINE (2011)
Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
Beibei Lu et al.
BMC INFECTIOUS DISEASES (2011)
New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines
Otis Brawley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Invasive Cervical Cancer and Screening: What Are the Rates of Unscreened and Underscreened Women in the Modern Era?
Akila Subramaniam et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2011)
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
Gina S. Ogilvie et al.
BMC CANCER (2010)
Practice Improvement in Cervical Screening and Management (PICSM): Symposium on Management of Cervical Abnormalities in Adolescents and Young Women
Anna-Barbara Moscicki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme
Ahti Anttila et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
HPV Screening for Cervical Cancer in Rural India
Rengaswamy Sankaranarayanan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
Peter Sasieni et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The psychosocial impact of human papillomavirus testing in primary cervical screening - a study within a randomized trial
H. C. Kitchener et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Screening-preventable cervical cancer risks:: Evidence from a nationwide audit in Sweden
Bengt Andrae et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Antenatal exposure to DES: Lessons learned ... future concerns
Mary M. Rubin
OBSTETRICAL & GYNECOLOGICAL SURVEY (2007)
Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
Aagje G. Bais et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Regression of low-grade squamous intra-epithelial lesions in young women
AB Moscicki et al.
LANCET (2004)
Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence
M Zappa et al.
BRITISH JOURNAL OF CANCER (2004)
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
P Sasieni et al.
BRITISH JOURNAL OF CANCER (2003)
American Cancer Society guideline for the early detection of cervical neoplasia and cancer
D Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening
IG Dzuba et al.
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE (2002)
Share Paper
